The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Eli Lilly shares rose as much as 13% after the company announced positive Phase 3 results for its oral drug orforglipron on April 17, 2025, according to market commentary from XTB. The trial did not show that the pill was as effective as Ozempic or Mounjaro: ACHIEVE-1 compared orforglipron with placebo in adults with type 2 diabetes, not with either named medicine. Since then, Lilly has reported FDA approval of the drug as Foundayo for a specified weight-management use in the United States in April 2026.
Why did Eli Lilly shares rise as much as 13%?
The immediate catalyst was Lilly’s April 17, 2025 announcement of results from ACHIEVE-1, a Phase 3 study of orforglipron in adults with type 2 diabetes. XTB reported that Lilly shares rose as much as 13% after the announcement. That is a reported peak reaction at the time, not a measure of the stock’s current price or subsequent return.
The news mattered to investors because it added positive late-stage trial data for an oral GLP-1 medicine to Lilly’s pipeline. But a one-day market move is not evidence that a drug will match competitors commercially, nor does it by itself support an investment decision.
What did the orforglipron trial show?
ACHIEVE-1 tested the pill against placebo
Lilly’s 40-week ACHIEVE-1 trial enrolled 559 adults with type 2 diabetes whose blood sugar was not adequately controlled with diet and exercise alone. Participants were randomized across the United States, China, India, Japan, and Mexico. The study’s primary endpoint was reduction in A1C, a measure of average blood glucose. Average weight reduction in the highest-dose group was a key secondary endpoint.
#1 Best Overall
- CLINICALLY PROVEN ACCURACY: Track and manage your diabetes confidently with our reliable blood glucose monitoring system. Readings that are personalized, HI/LO target ranges, and easy-to-understand summaries of your blood sugar test results (1)
- BLUETOOTH CONNECTIVITY: Sync your glucose monitor kit and get readings automatically to a free app via Bluetooth for seamless tracking and data sharing with our blood sugar testing kit
- EASY TO USE: SmartLIGHT target range indicator (2) instantly shows if blood sugar levels are above, below, or within target range for quick, clear feedback
- SECOND-CHANCE SAMPLING (3): Apply additional blood to the same test strip within 60 seconds to help reduce strip waste, avoid unnecessary retesting, and save money over time with our blood sugar testing kit
- NO CODING REQUIRED: Get fast, accurate results without the hassle of manual coding, reducing the risk of user error and making testing simpler, quicker, and more reliable
In that highest-dose group, Lilly reported an average 7.9% weight reduction at 40 weeks. The result came from a trial in people with type 2 diabetes, and the comparator was placebo. It should not be read as a direct comparison with Ozempic or Mounjaro.
Why the “as effective as” claim is not established
ACHIEVE-1 did not randomize participants to orforglipron versus semaglutide (Ozempic) or tirzepatide (Mounjaro). A placebo-controlled result can show that a medicine performed better than placebo under the conditions of that study; it cannot establish equivalence or superiority to another medicine that was not tested in the same trial.
Rank #2
- Advanced Blood Glucose Meter Kit: The Metene TD-4116 diabetes testing kit utilizes advanced technology to provide more accurate and reliable test results, helping you better control your blood sugar levels. After opening the test strip, it is valid for 6 months. Please refer to the test strip storage instructions in the user manual.
- Easy to Use: The blood glucose monitor is with code-free design, ready for testing once insert the strip correctly; the quick guide inside the package lists the steps to do a test clearly, easy to follow; any problem about operation, we are here ready to answer and provide glucose monitoring system instructional videos
- 7 Seconds And 0.7µl Blood: This blood glucose meter kit just needs 0.7 microliter blood sample and 7 seconds to get you blood glucose value; Fast, minimizes wound and less painful
- More Clearly Glucose Trend: 4 modes to record your glucose value according to different time, shows your glucose trend more clearly; 450 blood sugar values storage, continuous 14/21/28/60/90 day average, which brings more convenient Diabetes management for you and your health provider
- User-friendly for The Aged: 4 reminder alarms could be set everyday to remind the aged to do a test in time, considerate; the display is larger than most glucose monitors, showing the results more clearly, easier to read for the aged
Comparisons across separate studies can be misleading because enrolled patients, treatment duration, doses, endpoints, and analysis methods may differ. The later obesity data for Foundayo also came from a separate placebo-controlled study, not a head-to-head comparison with Ozempic or Mounjaro.
What is Lilly’s weight-loss pill, and what is Foundayo?
Orforglipron is an oral, small-molecule GLP-1 receptor agonist. Lilly announced ACHIEVE-1 as the first of seven Phase 3 studies examining its safety and efficacy across people with diabetes and obesity. In April 2026, Lilly said the FDA had approved orforglipron under the brand name Foundayo for adults with obesity, or adults with overweight and at least one weight-related medical problem, to be used with a reduced-calorie diet and increased physical activity.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Rank #3
- Note: No control solution in the kit. Including 2 AAA batteries.
- Accurate and Advanced Testing: Our glucose monitor meets and exceeds ISO 15197:2015 standards, measurements within ±10% of laboratory results (±15% required). The 20-600 mg/dL range ensures accurate, reliable performance for all users, including the elderly, pregnant women, and children. Enhanced with hypo and ketone alerts, it provides a safe, trusted solution for daily diabetes management.
- Talking Function and 1000 Memory Storage: This blood glucose meter also has a voice function, which can guide you through the operation steps and broadcast blood glucose readings through voice, which is very friendly to the elderly, people with poor vision and beginners in blood sugar management. If necessary, the volume can be adjusted to "0" to turn off the sound. Meanwhile, it can store up to 1000 records with date and time, and offers 7, 14, and 30-day test averaging. This feature allows for better long-term glucose trend analysis and more informed health decisions.
- Fast and Easy Testing in 5 Seconds: Our blood glucose monitor delivers results in just 5 seconds with a tiny 0.8µL blood sample. The 5-level adjustable lancing device, paired with 30G micro-pain lancets, minimizes discomfort during blood collection. The no-coding design makes it truly ready to use out of the box. With a clear voice guidance system that walks you through each step of testing and setup, it ensures effortless and accurate on-the-go monitoring for everyone.
- Suitable for All People: Designed with user-friendliness in mind, our glucose monitor kit is ideal for the entire family. The talking function, larger display, beep function, meal markers, and test alarms ensure ease of use, while the hypo and ketone warnings cater to different health needs, making it suitable for everyone from children to the elderly.
Lilly describes Foundayo as a once-daily prescription medicine that may be taken at any time of day without food or water restrictions. That is a practical dosing distinction; it is not evidence that its clinical effects equal those of another GLP-1 medicine.
What did the later obesity trial report?
Lilly’s April 2026 approval announcement described ATTAIN-1, a 72-week placebo-controlled obesity trial. Its highest-dose group had two reported average weight-loss figures, depending on the analysis population:
Rank #4
- NOTE: After installing the batteries and while the screen is off, simply insert a test strip to wake the meter—no need to press any buttons.
- Accurate and Reliable Testing: LinkSun G-425-1 blood glucose meter adopts advanced detection and production technology to provide more accurate and reliable results. It has an accuracy of up to ±12%, complies with the ISO 15197:2015 standard, and has not had any market recalls in the past 20 years. A control solution is included for checking the glucometer and strips.
- Simple and Easy to Use: The blood glucose meter adopts a no-coding design and can be tested after inserting the test strip; a quick guide is included in the package, which clearly lists the test steps and is easy to follow; if you have any operational problems, we are always available to provide help and tutorials on the blood glucose monitoring system video.
- Quick Test Time: Ready out of the box, just 5 seconds countdown for daily testing. 5 levels of lancing strengths with 5 the deepest depth suits differnt types of finger skins.
- Control Solution Mode: Always switch to CTL Mode before using control solution. After inserting the test strip, press and hold the “M” button until the “CTL” icon appears in the upper right corner of the screen. Testing without CTL Mode may give incorrect results. Press and hold “M” again to return to blood measurement mode.
| ATTAIN-1 highest-dose analysis | Average weight loss | Population represented |
|---|---|---|
| Participants who stayed on treatment | 27.3 pounds (12.4%) | Participants who remained on treatment |
| Participants regardless of trial completion | 25 pounds (11.1%) | Participants whether or not they completed the trial |
These are distinct analyses of the same trial, not interchangeable estimates. Neither figure is a direct comparison with Ozempic or Mounjaro.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What should patients know about tolerability and access?
Trial-specific adverse events
In ACHIEVE-1, gastrointestinal events were among the most commonly reported adverse events. Lilly reported that participants discontinued treatment because of adverse events at rates of 6%, 4%, and 8% in the three orforglipron dose groups, respectively, compared with 1% in the placebo group. Those percentages describe that trial; they are not a substitute for the medicine’s full prescribing information or an individual assessment by a clinician.
Best Value
- [Complete Starter Kit] - CareSens N Diabetes Testing Kit includes 1 blood glucose meter, 100 blood sugar test trips, 1 lancing device, 100 lancets, and a traveling case to provide you with the most affordable and convenient way for blood sugar testing. Our blood sugar test kit saves up to 250 tests and has a battery life of 1000 tests.
- [Small Sample Size] - CareSens N Plus Blood Sugar Monitor requires only a small blood sample size of 0.5 μL, making finger pricking easy and painless. CareSens N Diabetes Test Strip is auto coded and automatically recognizes the batch code encrypted on CareSens N Blood Glucose Test Strip.
- [Fast Results] - CareSens N Blood Glucose Meter provides fast results in just 5 seconds, making blood sugar testing fast and convenient. Our Glucometer Kit comes with a handy traveling case that can hold all your diabetes testing kit so that you can measure your blood sugar at the comfort of your home or anywhere else.
- [Easy to use] – CareSens N Blood Glucose Monitor kit is very simple and easy-to-use, making blood sugar testing easy for all. Our lightweight Blood Sugar Monitor has a simple design to make diabetes testing easy-to-understand and hassle-free.
- [Customer Service] - CareSens N Diabetes Testing Kit has a dedicated customer service team to provide you the best service to any issues or problems you're having! Our goal is to help you Sense Ahead of your Diabetes and Care for those you love. Your satisfaction is our number one priority. If you have any questions or concerns about your glucometer with strips and lancets – please contact us at any time.
U.S. availability reported in 2026
Lilly reported that Foundayo became available in the United States in April 2026 through LillyDirect, telehealth providers, and retail pharmacies. Availability, prescribing requirements, and access arrangements can change. Patients should consult a licensed health professional and current official prescribing information for suitability, risks, and use.
What the headline means for investors
The 13% figure captures a reported market reaction to a specific announcement in April 2025. The underlying trial offered positive placebo-controlled evidence, but it did not prove equivalence to Ozempic or Mounjaro. Foundayo’s subsequent FDA approval and reported U.S. launch are later developments that may be relevant to Lilly’s business, but neither the historical share move nor the trial results alone establish how the stock will perform.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
